
TOTAL VIEWS: 1066
Objective: To analyze the effect of tetrahedral framework nucleic acids (tFNAs) on the PI3K/AKT signaling pathway regulating vascular endothelial growth factor (VEGF) gene expression in oral submucous fibrosis (OSF). Methods: Six-week-old SD rats were selected to establish an OSF model. Each group was injected with the corresponding drugs for four weeks before being euthanized. Buccal mucosal tissues were collected for histopathological examination using H&E and Masson staining, as well as immunofluorescence. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to detect the expression levels of the PI3K/AKT signaling pathway and its phosphorylation, angiogenesis-related factors (CD34, VEGF), and fibrosis-related factors (type I collagen, COL-I; α-smooth muscle actin, α-SMA) in the buccal mucosa. Results: tFNAs inhibited the pathological progression of OSF, reduced collagen deposition, and improved the severity of OSF in rats. By upregulating the PI3K/AKT signaling pathway and its phosphorylation levels in OSF mucosal tissues, tFNAs increased the expression of angiogenesis-related factors (CD34 and VEGF) while decreasing fibrosis-related factors (COL-I and α-SMA). Conclusion: tFNAs activate the PI3K/AKT signaling pathway to promote VEGF gene expression, enhance angiogenesis, and amelio-rate OSF. This confirms the critical role of angiogenesis in OSF treatment.
Tetrahedral framework nucleic acids; Oral submucous fibrosis; PI3K/AKT signaling pathway; Vascular endothelial growth factor
[1] Ray JG, Chatterjee R, Chaudhuri K. Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities. Periodontol 2000. 2019;80(1):200-12.
[2] Pavan Kumar B, Narra P, Vidya Devi V, et al. Prevalence of premalignant conditions and their transformation into oral cancers: a clinical study. J Pharm Bioallied Sci. 2024;16(Suppl 3):S2563-5.
[3] Bayraktar B, Turkoz D, Turkoz A. Effects of cerebral ischemia on levels of vascular endothelial growth factor (VEGF) and its soluble receptors: a possible link to angiogenesis in arteriovenous malformations. Turk Neurosurg. 2021;31(6):907-12.
[4] Wang H, Gao L, Zhao C, et al. The role of PI3K/Akt signaling pathway in chronic kidney disease. Int Urol Nephrol. 2024;56(8):2623-33.
[5] Zhang X, Liu N, Zhou M, et al. The application of tetrahedral framework nucleic acids as a drug carrier in biomedicine fields. Curr Stem Cell Res Ther. 2021;16(1):48-56.
[6] Arakeri G, Rao US, Patil S, et al. Evaluation of possible role of fluoride in pathogenesis of oral submucous fibrosis: a pilot study. J Oral Pathol Med. 2024;53(3):226-31.
[7] Mao T, Yang L, Xiong H, et al. Traditional Chinese medication for oral submucous fibrosis: a systematic review and network meta-analysis of randomized controlled trials. Oral Dis. 2024;30(4):1897-911.
[8] Sun Y, Chen X, Shi S. Tetrahedral framework nucleic acids: a novel strategy for antibiotic treating drug-resistant infections. Biomacromolecules. 2023;24(2):1052-60.
[9] He Y, Zhang Y, Wu H, et al. The role of annexin A1 peptide in regulating PI3K/Akt signaling pathway to reduce lung injury after cardiopulmonary bypass in rats. Perfusion. 2023;38(2):320-9.
[10] Jiang Y, Li S, Zhang T, et al. Tetrahedral framework nucleic acids inhibit skin fibrosis via the pyroptosis pathway. ACS Appl Mater Interfaces. 2022;14(13):15069-79.
The Effect of Tetrahedral Framework Nucleic Acids on the PI3K/AKT Signaling Pathway Regulating VEGF Gene Expression in Oral Submucous Fibrosis
How to cite this paper: Guanyu Sun, Tao Wang. (2025) The Effect of Tetrahedral Framework Nucleic Acids on the PI3K/AKT Signaling Pathway Regulating VEGF Gene Expression in Oral Submucous Fibrosis. International Journal of Clinical and Experimental Medicine Research, 9(4), 414-418.
DOI: http://dx.doi.org/10.26855/ijcemr.2025.07.004